Allogeneic stem cell therapy(Avicenna Research Institute)(Allogeneic stem cell therapy(Avicenna Research Institute))

概要

基本信息

药物类型

干细胞疗法

别名-

靶点-

作用机制

干细胞替代物

治疗领域

感染呼吸系统疾病其他疾病

在研适应症-

非在研适应症

新型冠状病毒感染细胞因子释放综合征

原研机构

Avicenna Research Institute

在研机构-

非在研机构

Avicenna Research Institute

最高研发阶段无进展临床1/2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

2

项与 Allogeneic stem cell therapy(Avicenna Research Institute) 相关的临床试验

NCT05019287 / Completed临床1/2期IIT

Safety and Efficacy Study of Allogeneic Human Menstrual Blood Stem Cells Secretome to Treat Severe Covid-19 Patients, Clinical Trial Phase I&II

In this randomized controlled trial (RCT), severe cases of COVID-19 infection will be treated with secretome of menstrual blood stem cells. The improvement in the clinical, laboratory and radiological manifestations will be evaluated in treated patients compared with the control group.

开始日期2021-04-17

申办/合作机构

Avicenna Research Institute

[+1]

NCT05703308 / Completed临床3期IIT

Outcome of Pregnancy in Poor Ovarian Responders by Intraovarian Administration of Autologous Menstrual Blood Derived-Mesenchymal Stromal Cells

In this controlled trial, poor ovarian responder women will be treated with transplantation of autologous menstrual blood stem cells. The investigators will attempt to assess the safety and efficacy of this procedure for the treatment of infertility in POR patients compared to control group.

开始日期2020-06-21

申办/合作机构

Avicenna Research Institute

100 项与 Allogeneic stem cell therapy(Avicenna Research Institute) 相关的临床结果

登录后查看更多信息

100 项与 Allogeneic stem cell therapy(Avicenna Research Institute) 相关的转化医学

登录后查看更多信息

100 项与 Allogeneic stem cell therapy(Avicenna Research Institute) 相关的专利（医药）

登录后查看更多信息

100 项与 Allogeneic stem cell therapy(Avicenna Research Institute) 相关的药物交易

登录后查看更多信息

研发状态

10 条进展最快的记录,

登录

后查看更多信息

适应症	最高研发状态	国家/地区	公司	日期
细胞因子释放综合征	临床2期	伊朗	Avicenna Research Institute	2021-04-17
新型冠状病毒感染	临床前	伊朗	Avicenna Research Institute	2021-04-17